-transparent.png){kind=logo}
In 19 patients with advanced pretreated breast cancer, vinblastine was administered by continuous venous infusion (2 mg/m2/24 h for 120 h every 3 weeks), using a totally implanted venous access and a portable pump. A total of 55 courses were given. Five objective responses were observed. Drug-related toxicity consisted mainly of leukopenia (4 patients), fever (4 patients) and nausea and vomiting (3 patients). Catheter-related toxicity was observed in 4 patients (21%) and consisted of infection of the skin pocket in 1 patient and dislodging of the needle with drug extravasation in 3 patients.
Related Publications
P Pronzato, and
P Queirolo, and
M G Vidili, and
D Amoroso, and
G Bertelli, and
M R Sertoli, and
R Rosso
October 1987,
Cancer,
P Pronzato, and
P Queirolo, and
M G Vidili, and
D Amoroso, and
G Bertelli, and
M R Sertoli, and
R Rosso
November 1987,
Cancer treatment reports,
P Pronzato, and
P Queirolo, and
M G Vidili, and
D Amoroso, and
G Bertelli, and
M R Sertoli, and
R Rosso
October 1982,
American journal of clinical oncology,
P Pronzato, and
P Queirolo, and
M G Vidili, and
D Amoroso, and
G Bertelli, and
M R Sertoli, and
R Rosso
July 1985,
Cancer,
P Pronzato, and
P Queirolo, and
M G Vidili, and
D Amoroso, and
G Bertelli, and
M R Sertoli, and
R Rosso
August 1988,
American journal of clinical oncology,
P Pronzato, and
P Queirolo, and
M G Vidili, and
D Amoroso, and
G Bertelli, and
M R Sertoli, and
R Rosso
May 1984,
Cancer treatment reports,
P Pronzato, and
P Queirolo, and
M G Vidili, and
D Amoroso, and
G Bertelli, and
M R Sertoli, and
R Rosso
April 1985,
Gan to kagaku ryoho. Cancer & chemotherapy,
P Pronzato, and
P Queirolo, and
M G Vidili, and
D Amoroso, and
G Bertelli, and
M R Sertoli, and
R Rosso
January 1989,
Anticancer research,
P Pronzato, and
P Queirolo, and
M G Vidili, and
D Amoroso, and
G Bertelli, and
M R Sertoli, and
R Rosso
April 1993,
American journal of clinical oncology,
P Pronzato, and
P Queirolo, and
M G Vidili, and
D Amoroso, and
G Bertelli, and
M R Sertoli, and
R Rosso
January 1985,
Cancer treatment reports,
